Skip to main content
SpringerLink
Log in

The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer

  • Perspectives
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

Cell-mediated immunity is often impaired in cancer. This may be partly due to increased amounts of prostaglandin E2 (PGE2) and histamine in the blood of cancer patients, since PGE2 and histamine possess inhibitory effects on cellular immunity. These effects are mediated by cyclic AMP (cAMP), which is increased in leukocytes by PGE2 through EP2 and by histamine through H2 receptors and also by epinephrine through β2-adrenergic receptors. Increased cAMP activates protein kinase A, which inhibits the formation of interleukin 2 (IL-2) in T cells. The formation of interferon y is concomitantly decreased, and cellular immunity is attenuated. In monocyte/macrophages the formation of IL-1β, IL-12 and tumor necrosis factor a is decreased by cAMP or through the increased formation of IL-10, which is up-regulated by cAMP. This attenuates cellular immunity. In monocytes histamine may decrease the formation of oxygen intermediates, which can induce apoptosis of natural killer cells and thus inhibit immunity. The superoxide anion is a potent inducer of the cyclooxygenase-2 enzyme, which is upregulated in colorectal cancer. Cyclooxygenase-2 catalyzes the formation of PGE2, e. g. in cancer cells. Thus the inhibition of cellular immunity in cancer may be at least partly mediated by cAMP and oxygen intermediates. This may offer new options for cancer immunotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abramson SL, Gallin JI (1990) IL-4 inhibits superoxide production by human mononuclear phagocytes. J Immunol 144: 625

    CAS  PubMed  Google Scholar 

  2. Anastassiou ED, Paliogianni F, Balow JP, Yamada H, Boumpas DT (1992) Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2Rα gene expression at multiple levels. J Immunol 148: 2845

    CAS  PubMed  Google Scholar 

  3. Angel P, Karin M (1991) The role of Jun, Fos and AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072: 129

    CAS  PubMed  Google Scholar 

  4. Arend WP, Gordon OF, Wood WM, Janson RW, Joskin FG, Jameel S (1989) IL-1β production in cultured human monocytes is regulated at multiple levels. J Immunol 143: 118

    CAS  PubMed  Google Scholar 

  5. Arias J, Alberts AS, Brindle P, Claret FX, Smeal T, Karin M, Feramisco J, Montminy M (1994) Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370: 226

    Article  CAS  PubMed  Google Scholar 

  6. Aste-Amezaga M, D'Andrea A, Kubin M, Trinchieri G (1994) Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell Immunol 156: 480

    Article  CAS  PubMed  Google Scholar 

  7. Barinaga M (1995) Two major signaling pathways meet at MAP-kinase. Science 269: 1673

    Article  CAS  PubMed  Google Scholar 

  8. Bast A, Savenije-Chapel EM, Kroes BH (1984) Inhibition of mono-oxygenase and oxidase activity of rat-hepatic cytochrome P-450 by H2-receptor blockers. Xenobiotica 14: 399

    Article  CAS  PubMed  Google Scholar 

  9. Bauman GP, Bartik MM, Brooks WH, Roszman TL (1994) Induction of cAMP-dependent protein kinase (PKA) activity in T cells after stimulation of the prostaglandin E2 or the β-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation. Cell Immunol 158: 182

    Article  CAS  PubMed  Google Scholar 

  10. Bennet A, Civier A, Hensby CN, Melhuish PB, Stamford IF (1987) Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues. Gut 28: 315

    Article  Google Scholar 

  11. Beutler B, Van Huffel C (1994) Unraveling function in the TNF ligand and receptor families. Science 264: 667

    Article  CAS  PubMed  Google Scholar 

  12. Bravo R, Nueberg M, Burckhardt J, Almendral J, Wallich R, Müller R (1987) Involvement of common and cell type-specific pathways in c-fos gene control: Stable induction by cAMP in macrophages. Cell 48: 251

    Article  CAS  PubMed  Google Scholar 

  13. Brodde O-E, Engel G, Hoyer D, Bock KD, Weber F (1981) The β-adrenergic receptor in human lymphocytes: subclassification by the use of a new radioligand (+)-125iodocyanopindolol. Life Sci 29: 2189

    Article  CAS  PubMed  Google Scholar 

  14. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G (1991) Induction of interferon y production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 173: 869

    Article  CAS  PubMed  Google Scholar 

  15. Chiu R, Angel P, Karin M (1989) Jun-B differs in its biological properties from, and is a negative regulator of, cJun. Cell 59: 979

    Article  CAS  PubMed  Google Scholar 

  16. Coleman RA, Smith WL, Narumiya S (1994) VIII International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacal Rev 46: 205

    CAS  Google Scholar 

  17. Cook SJ, McCormick F (1993) Inhibition by cAMP of Ras-dependent activation of Raf. Science 262: 1069

    Article  CAS  PubMed  Google Scholar 

  18. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G (1993) Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178: 1041

    Article  PubMed  Google Scholar 

  19. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209

    Article  PubMed  Google Scholar 

  20. Di Giovine F, Duff GW (1990) lnterleukin 1: the first interleukin. Immunol Today 11: 13

    Article  PubMed  Google Scholar 

  21. Dohlsten M, Sjögren HO, Carlsson R (1987) Histamine acts directly on human T cells to inhibit interleukin-2 and interferon-γ production. Cell Immunol 109: 65

    Article  PubMed  Google Scholar 

  22. Dohlsten M, Hedlund G, Fischer H, Sjögren HO, Carlsson R (1989) Proliferation of human CD4+45R+ and CD+45R- T helper cells is promoted by both IL-2 and IL-4 while interferon-gamma production is restricted to IL-2 activated CD4+45R- T cells. Immunol Lett 20: 29

    Article  CAS  PubMed  Google Scholar 

  23. Donnelly RP, Fenton MJ, Kaufmann JD, Gerrard TL (1991) IL-1 expression in human monocytes is transcriptionally and posttranscriptionally regulated by IL-4. J Immunol 146: 3431

    CAS  PubMed  Google Scholar 

  24. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, Dubois RN (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183

    Article  CAS  PubMed  Google Scholar 

  25. Emorine LJ, Marullo S, Delavier-Klutchko C, Kaveri SV, Durieu-Trautmann O, Strosberg AD (1987) Structure of the gene for human β2-adrenergic receptor: expression and promoter characterization. Proc Natl Acad Sci USA 84: 6995

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Engelhard VH (1994) How cells process antigens. Sci Am 271: 44

    Article  Google Scholar 

  27. Essner R, Rhoades K, McBride WH, Morton DL, Economou JS (1989) IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol 142: 3857

    CAS  PubMed  Google Scholar 

  28. Feng L, Xia Y, Garcia GE, Hwang D, Wilson CB (1995) Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α, and lipopolysaccharide. J Clin Invest 95: 1669

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Fiorentino OF, Zlotnik A, Mosmann TR, Howard M, O'Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147: 3815

    CAS  PubMed  Google Scholar 

  30. Fischer H, Hedlund G, Kalland T, Sjögren HO, Dohlsten M (1990) Independent regulation of IFN-γ and tumor necrosis factor by IL-1 in human T helper cells. J Immunol 145: 3767

    CAS  PubMed  Google Scholar 

  31. Freeman BA, Crapo JD (1982) Biology of disease: free radicals and tissue injury. Lab Invest 47: 412

    CAS  PubMed  Google Scholar 

  32. Galbraith RA, Michnovicz JJ (1989) The effects of cimetidine on the oxidative metabolism of estradiol. N Engl J Med 321: 269

    Article  CAS  PubMed  Google Scholar 

  33. Gantz I, Munzert G, Tashiro T, Schäffer M, Wang L, DelValle J, Yamada T (1991) Molecular cloning of human histamine H2 receptor. Biochem Biophys Res Commun 178: 1386

    Article  CAS  PubMed  Google Scholar 

  34. Garcia-Penarrubia P, Bankhurst AD, Koster FT (1989) Prostaglandins from human T suppressor/cytotoxic cells modulate natural killer antibacterial activity. J Exp Med 170: 601

    Article  CAS  PubMed  Google Scholar 

  35. Gastl G, Niederwieser D, Marth C, Huber H, Egg D, Schuler G, Margreiter R, Braunsteiner H, Huber C (1984) Human large granular lymphocytes and their relationship to natural killer cell activity in various disease states. Blood 64: 288

    CAS  PubMed  Google Scholar 

  36. Goodman Gilman A, Rail TW, Nies AS, Taylor P ( 1990) Goodman and Gilman's The pharmacological basis of therapeutics, 8th edn. Pergamon, New York

    Google Scholar 

  37. Goto T, Herberman RB, Maluish A, Strong OM (1983) Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity. J Immunol 130: 1350

    CAS  PubMed  Google Scholar 

  38. Halliwell B, Gutteridge JMC (1991) Free radicals in biology and medicine, 2nd edn. Clarendon, Oxford

    Google Scholar 

  39. Hansson M, Asea A, Ersson U, Hermodsson S, Hellstrand K (1996) Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites. J Immunol 156: 42

    CAS  PubMed  Google Scholar 

  40. Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli OS, Hamilton JA (1989) Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor α, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci USA 86: 3803

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Hart PH, Whitty GA, Piccoli OS, Hamilton JA (1989) Control by IFN-γ and PGE2 of TNFα and IL-1 production by human monocytes. Immunology 66: 376

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Hellstrand K, Hermodsson S ( 1987) Differential effects of histamine receptor antagonists on human natural killer cell activity. Int Arch Allergy Appl Immunol 84: 247

    Article  CAS  PubMed  Google Scholar 

  43. Hellstrand K, Hermodsson S (1989) An immunopharmacological analysis of adrenaline-induced suppression of human natural killer cell cytotoxicity. Int Arch Allergy Appl Immunol 89: 334

    Article  CAS  PubMed  Google Scholar 

  44. Hellstrand K, Hermodsson S (1990) A cell-to-cell mediated interaction involving monocytes and non-T/CD16+ natural killer (NK) cells is required for histamine H2-receptor-mediated NK-cell activation. Scand J Immunol 31: 631

    Article  CAS  PubMed  Google Scholar 

  45. Hellstrand K, Asea A, Hermodsson S (1990) Role of histamine in natural killer cell-mediated resistance against tumor cells. J lmmunol 145: 4365

    CAS  Google Scholar 

  46. Hellstrand K, Asea A, Dahlgren C, Hermodsson S (1994) Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites. J Immunol 153: 4940

    CAS  PubMed  Google Scholar 

  47. Honda A, Sugimoto Y, Namba T, Watabe A, Irie A, Negishi M, Narumiya S, Ichikawa A (1993) Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. J Biol Chem 268: 7759

    CAS  PubMed  Google Scholar 

  48. Hotermans G, Bury T, Radermecker MF (1991) Effect of histamine on tumor necrosis factor production by human monocytes. Int J Allergy Appl Immunol 95: 278

    Article  CAS  Google Scholar 

  49. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, Silvennoinen O (1994) Signaling by the cytokine receptor superfamily; JAKs and STATs. Trends Biochem Sci 19: 222

    Article  CAS  PubMed  Google Scholar 

  50. Israel A (1994) NF-AT comes under control. Nature 369: 443

    Article  CAS  PubMed  Google Scholar 

  51. Jain J, McCaffrey PG, Valge-Archer VE, Rao A (1992) Nuclear factor of activated T cells contains Fos and Jun. Nature 356: 801

    Article  CAS  PubMed  Google Scholar 

  52. Jones DA, Carlton DP, Mcintyre TM, Zimmerman GA, Prescott SM (1993) Molecular cloning of human prostaglandin endoperoxide synthase Type II and demonstration of expression in response to cytokines. J Biol Chem 268: 9049

    CAS  PubMed  Google Scholar 

  53. Kammer GM (1988) The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today 9: 222

    Article  CAS  PubMed  Google Scholar 

  54. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S (1995) Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 55: 2556

    CAS  PubMed  Google Scholar 

  55. Katz P, Zaytoun AM, Fauci AS (1982) Mechanisms of human cell-mediated cytotoxicity. I. Modulation of natural killer cell activity by cyclic nucleotides. J Immunol 129: 287

    CAS  PubMed  Google Scholar 

  56. Khan MM, Sansoni P, Engleman EG, Melmon KL (1985) Pharmacologic effects of autacoids on subsets of T cells. J Clin Invest 75: 1578

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Khan MM, Sansoni P, Silverman ED, Engleman EG, Melmon KL (1986) Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytes. Biochem Pharmacol 35: 1137

    Article  CAS  PubMed  Google Scholar 

  58. Kishimoto T, Taga T, Akira S (1994) Cytokine signal transduction. Cell 76: 253

    Article  CAS  PubMed  Google Scholar 

  59. Knodell RG, Browne DG, Gwozdz GP, Brian WR, Guengerich FP (1991) Differential inhibition of individual human liver cytochromes P-450 by cimetidine. Gastroenterology 101: 1680

    Article  CAS  PubMed  Google Scholar 

  60. Kobayaski M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J Exp Med 170: 827

    Article  Google Scholar 

  61. Kobilka BK, Dixon RA, Frielle T, Dohlman HG, Bolanowski MA, Sigal IS, Yang-Feng TL, Francke U, Caron MG, Lefkowitz RJ (1987) eDNA for the human β2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci USA 84: 46

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Kobilka BK, Matsui H, Kobilka TS, Yang-Feng TL, Francke U, Caron MG, Lefkowitz RJ, Regan JW (1987) Cloning, sequencing, and expression of the gene coding for the human platelet α2-adrenergic receptor. Science 238: 650

    Article  CAS  PubMed  Google Scholar 

  63. Krause DS, Deutsch C (1991) Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: expression of both p55 and p75 subunits is affected. J Immunol 146: 2285

    CAS  PubMed  Google Scholar 

  64. Kubota Y, Sunouchi K, Ono M, Sawaka T, Muto T (1992) Local immunity and metastasis of colorectal carcinoma. Dis Colon Rectum 35: 645

    Article  CAS  PubMed  Google Scholar 

  65. Kunkel SL, Spengler M, May MA, Spengler R, Larrick J, Remick D (1988) Prostaglandin Ez regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 263: 5380

    CAS  PubMed  Google Scholar 

  66. Kärre K, Hansson M, Kiessling R (1991) Multiple interactions at the natural killer workshop. Immunol Today 12: 343

    Article  PubMed  Google Scholar 

  67. Last-Barney K, Homon CA, Faanes RB, Merluzzi VJ (1988) Synergistic and overlapping activities of tumor necrosis factor-α and IL-1. J Immunol 141: 527

    CAS  PubMed  Google Scholar 

  68. Lehn M, Weiser WY, Engelhom S, Gillis S, Remold HG (1989) IL-4 inhibits H2O2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-γ. J Immunol 143: 3020

    CAS  PubMed  Google Scholar 

  69. Liou H-C, Baltimore D (1993) Regulation of the NK-kB/rel transcription factor and IkB inhibitor system. Curr Opin Cell Biol 5: 477

    Article  CAS  PubMed  Google Scholar 

  70. Marx J (1993) Forging a path to the nucleus. Science 260: 1588

    Article  CAS  PubMed  Google Scholar 

  71. Marx J (1993) Two major signal pathways linked. Science 262: 988

    Article  CAS  PubMed  Google Scholar 

  72. Mary D, Aussel C, Ferrua B, Fehlmann M (1987) Regulation of interleukin2 synthesis by cAMP in human T cells. J Immunol 139: 1179

    CAS  PubMed  Google Scholar 

  73. McCaffrey PG, Luo C, Kerppola TK, Jain J, Badalian TM, Ho AM, Burgeon E, Lane WS, Lambert JN, Curran T, Verdine GL, Rao A, Hogan PG (1993) Isolation of cyclosporin-sensitive T cell transcription factor NFATp. Science 262: 750

    Article  CAS  PubMed  Google Scholar 

  74. McLemore TL, Hubbard WC, Litterst CL, Liu MC, Miller S, McMahon NA, Eggleston JC, Boyd MR (1988) Profiles of prostaglandin biosynthesis in normal lung and tumor tissue from lung cancer patients. Cancer Res 48: 3140

    CAS  PubMed  Google Scholar 

  75. Meade EA, Smith WL, DeWitt DL (1993) Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal antiinflammatory drugs. J Biol Chem 268: 6610

    CAS  PubMed  Google Scholar 

  76. Merluzzi VJ, Faanes RB, Czajkowski M, Last-Barney K, Harrison PC, Kahn J, Rothlein R (1987) Membrane-associated interleukin 1 activity on human U937 tumor cells: stimulation of PGEz production by human chondrosarcoma cells. J Immunol 139: 166

    CAS  PubMed  Google Scholar 

  77. Mertz PM, DeWitt DL, Stetler-Stevenson WG, Wahl LM (1994) Interleukin 10 suppression of monocyte prostaglandin H synthase-2. J Biol Chem 269: 21322

    CAS  PubMed  Google Scholar 

  78. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR (1993) Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 90: 11 693

    Article  CAS  Google Scholar 

  79. Moriarty CM, Stucky JL, Hamburger KW, Patil KD, Foley JF, Koefoot RR (1988) Blood histamine and solid malignant tumors. J Cancer Res Clin Oncol 114: 588

    Article  CAS  PubMed  Google Scholar 

  80. Narisawa T, Kusaka H, Yamazaki Y, Takahashi M, Koyama H, Koyama K, Fukaura Y, Wakizaka A (1990) Relationship between blood plasma prostaglandin E2 and liver and lung metastases in colorectal cancer. Dis Colon Rectum 33: 840

    Article  CAS  PubMed  Google Scholar 

  81. Newton RC (1985) Effect of interferon on the induction of human monocyte secretion of interleukin-1 activity. Immunol 56: 441

    CAS  Google Scholar 

  82. Niiro H, Otsuka T, Tanabe T, Hara S, Kuga S, Nemoto Y, Tanaka Y, Nakashima H, Kitajima S, Abe M, Niho Y (1995) Inhibition by interleukin-10 of inducible cyclooxygenase expression in lipopolysaccharide-stimulated monocytes: its underlying mechanism in comparison with interleukin-4. Blood 85: 3736

    CAS  PubMed  Google Scholar 

  83. Northrop JP, Ullman KS, Crabtree GR (1993) Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex. J Biol Chem 268: 2917

    CAS  PubMed  Google Scholar 

  84. Northrop JP, Ho SN, Chen L, Thomas DJ, Timmerman LA, Nolan GP, Admon A, Crabtree GR (1994) NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369: 497

    Article  CAS  PubMed  Google Scholar 

  85. O'Banion MK, Winn VD, Young DA (1992) eDNA cloning and functional activity of glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 89: 4888

    Article  PubMed  PubMed Central  Google Scholar 

  86. Ogasawara H, Fujitani T, Drzewiecki G, Middleton E (1986) The role of hydrogen peroxide in basophil histamine release and the effect of selected flavonoids. J Allergy Clin Immunol 78: 321

    Article  CAS  PubMed  Google Scholar 

  87. Ozaki M, Morii H, Qvist R, Watanabe Y (1994) Interleukin-1β induces cytosolic phospholipase A2 gene in rat C6 glioma cell line. Biochem Biophys Res Commun 205: 12

    Article  CAS  PubMed  Google Scholar 

  88. Paul WE, Seder RA (1994) Lymphocyte responses and cytokines. Cell 76: 241

    Article  CAS  PubMed  Google Scholar 

  89. Pelkonen O, Breimer DO (1994) Role of environmental factors in the pharmacokinetics of drugs: considerations with respect to animal models, P-450 enzymes, and probe drugs: In: Welling PG, Balant LP (eds) Handbook of experimental pharmacology, vol 110. Pharmacokinetics of drugs. Springer, Berlin Heidelberg New York, pp 289

    Google Scholar 

  90. Pene J, Rousset F, Briere F, Chretien I, Paliard X, Banchereau J, Spits H, De Vries JE (1988) IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-γ. J Immunol 141: 1218

    CAS  PubMed  Google Scholar 

  91. Phipps RP, Stein SH, Roper RL (1991) A new view of prostaglandin E regulation of the immune response. Immunol Today 12: 349

    Article  CAS  PubMed  Google Scholar 

  92. Powell JR, Donn KH (1984) Histamine Hz-antagonist drug interactions in perspective: mechanistic concepts and clinical implications. Am J Med 77 [Suppl 5B]: 57

    CAS  PubMed  Google Scholar 

  93. Ralph P, Nakoinz I, Sampson-Johannes A, Fong S, Lowe D, Min H-Y, Lin L (1992) IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol 148: 808

    CAS  PubMed  Google Scholar 

  94. Ramstedt U, Ng J, Wigzell H, Serhan CN, Samuelsson B (1985) Action of novel eicosanoids lipoxin A and B on human natural killer cell cytotoxicity: effects of intracellular cAMP and target cell binding. J Immunol 135: 3434

    CAS  PubMed  Google Scholar 

  95. Riabowol KT, Fink JS, Gilman MZ, Walsh DA, Goodman RH, Feramisco JR (1988) The catalytic subunit of cAMP-dependent protein kinase induces expression of genes containing cAMPresponsive enhancer elements. Nature 336: 83

    Article  CAS  PubMed  Google Scholar 

  96. Rigas B, Goldman IS, Levine L (1993) Altered eicosanoid levels in human colon cancer. J Lab Clin Med 122: 518

    CAS  PubMed  Google Scholar 

  97. Rincon M, Tugores A, Lopez-Rivas A, Silva A, Alonso M, De Landazuri MO, Lopez-Botet M (1988) Prostaglandin E2 and the increase of intracellular cAMP inhibits the expression of interleukin-2 receptors in human T cells. Eur J Immunol 18: 1791

    Article  CAS  PubMed  Google Scholar 

  98. Ruco LP, Procopio A, Maccallini V, Calogero A, Uccini S, Annino L, Mandelli F, Baroni CD (1983) Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia. Blood 61: 1132

    CAS  PubMed  Google Scholar 

  99. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55: 3785

    CAS  PubMed  Google Scholar 

  100. Scott P (1993) IL-12: initiation cytokine for cell-mediated immunity. Science 26: 496

    Article  Google Scholar 

  101. Severn A, Rapson NT, Hunter CA, Liew FY (1992) Regulation of tumor necrosis factor production by adrenaline and β-adrenergic agonists. J Immunol 148: 3441

    CAS  PubMed  Google Scholar 

  102. Smith KA (1990) Interleukin-2. Sci Am 262: 26

    Article  Google Scholar 

  103. Smith WL, Marnett LJ (1991) Prostaglandin endoperoxide synthase: structure and catalysis. Biochim Biophys Acta 1083: 1

    Article  CAS  PubMed  Google Scholar 

  104. Soiffer RJ, Robertson MJ, Murray C, Cochran K, Ritz J (1993) Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies. Blood 82: 2790

    CAS  PubMed  Google Scholar 

  105. Spengler RN, Allen RM, Remick DG, Strieter RM, Kunkel SL ( 1990) Stimulation of a-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J Immunol 145: 1430

    CAS  PubMed  Google Scholar 

  106. Spengler RN, Chensue SW, Giacherio DA, Blenk N, Kunkel SL (1994) Endogenous norepinephrine regulates tumor necrosis factor-α production from macrophages in vitro. J Immunol 152: 3024

    CAS  PubMed  Google Scholar 

  107. Strassmann G, Patil-Koota V, Finkelman F, Fong M, Kambayashi T (1994) Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J Exp Med 180: 2365

    Article  CAS  PubMed  Google Scholar 

  108. Strieter RM, Remick DG, Ham JM, Colletti LM, Lynch JP, Kunkel SL (1990) Tumor necrosis factor-alpha gene expression in human blood. J Leukoc Biol 47: 366

    CAS  PubMed  Google Scholar 

  109. Subramanian N, Bray MA (1987) Interleukin 1 releases histamine from human basophils and mast cells in vitro. J Immunol 138: 271

    CAS  PubMed  Google Scholar 

  110. Theoharides TC, Kops SR, Bondy PK, Askenase PW (1985) Differential release of serotonin without comparable histamine under diverse conditions in the rat mast cell. Biochem Pharmacal 34: 1389

    Article  CAS  Google Scholar 

  111. Tønnesen H, Knigge U, Bülow S, Damm P, Fischerman K, Hesselfeldt P, Hjortrup A, Pedersen IK, Pedersen VM, Siemssen OJ, Svendsen LB, Christiansen PM (1988) Effect of cimetidine on survival after gastric cancer. Lancet 2: 990

    Article  PubMed  Google Scholar 

  112. Trinchieri G (1993) Interleukin-12 and its role in the generation of Thl cells. Immunol Today 14: 335

    Article  CAS  PubMed  Google Scholar 

  113. Trinchieri G, Wysocka M, D'Andrea A, Rengaraju M, Aste-Amezaga M, Kubin M, Valiante NM, Chehimi J (1992) Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. Prog Growth Factor Res 4: 355

    Article  CAS  PubMed  Google Scholar 

  114. Trinchieri G, Scott P (1994) The role of interleukin 12 in the immune response, disease and therapy. Immunol Today 15: 460

    Article  CAS  PubMed  Google Scholar 

  115. Uotila P (1993) Inhibition of prostaglandin Ez formation and histamine action in cancer immunotherapy. Cancer Immunol Immunother 37: 251

    Article  CAS  PubMed  Google Scholar 

  116. Uotila P, Vapaatalo H (1984) Synthesis, pathways and biological implications of eicosanoids. Ann Clin Res 16: 226

    CAS  PubMed  Google Scholar 

  117. Van der Pouw Kraan TCTM, Boeije LCM, Smeenk RJT, Wijdenes J, Aarden LA (1995) Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 181: 775

    Article  PubMed  Google Scholar 

  118. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW (1993) Inhibition of the EGF-activated AMP kinase signaling pathway by adenosine 3’,5’ -monophosphate. Science 262: 1065

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Physiology and Clinical Physiology, University of Turku, Kiinamyllynkatu 10, SF-20520, Turku, Finland

    Pekka Uotila

Authors
  1. Pekka Uotila
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pekka Uotila.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uotila, P. The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer. Cancer Immunol Immunother 43, 1–9 (1996). https://doi.org/10.1007/BF03354243

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03354243

Key words

Search

Navigation